share_log

HC Wainwright & Co. Maintains Buy on LAVA Therapeutics, Lowers Price Target to $6

HC Wainwright & Co. Maintains Buy on LAVA Therapeutics, Lowers Price Target to $6

HC Wainwright & Co.维持对LAVA Therapeutics的买入,将目标价下调至6美元
Benzinga ·  2023/08/23 06:17

HC Wainwright & Co. analyst Arthur He maintains LAVA Therapeutics (NASDAQ:LVTX) with a Buy and lowers the price target from $9 to $6.

HC Wainwright & Co. 分析师Arthur He将LAVA Therapeutics(纳斯达克股票代码:LVTX)维持买入,并将目标股价从9美元下调至6美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发